Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Genetic analysis of rabbits identified key genes for traits like coat color, body size, and fertility.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Low testosterone levels may lead to more severe COVID-19 outcomes.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

Minoxidil and finasteride are effective for treating hair loss, with dutasteride showing potential but with side effects.

The testes produce sperm and hormones essential for male development.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

No link found between aromatase gene and female hair loss.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

AR/EDA2R gene linked to early-onset female hair loss, but 20p11 gene not involved.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.